No news here
Looks like there's nothing to report right now
IVVD Doubled on Clinical Trial ResultsInvivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. Earnings in 48 days. Avg 30D Vol at 24.67M Current Vol at 74.70M
Can this break and retest $2.35? If it does analyst have targets as high as $10.
Invivyd Inc. Stock Quote | Chart & Forecast SummaryKey Indicators On Trade Set Up In General
1. Push Set Up
2. Range Set up
3. Break & Retest Set Up
Notes On Session
# Invivyd Inc. Stock Quote
- Double Formation
* (Neckline) | Completed Survey & Entry Bias
* 012345 | Wave Count Configuration | Subdivision 1
- Triple Formation
* Retracement Numbere
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.